Anebulo Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANEB Nasdaq 2836 www.anebulo.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Feb 12th, 2026 2:15 pm
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Feb 6th, 2026 7:00 am
Anebulo Pharmaceuticals Announces Final Results of Tender Offer - Jan 29th, 2026 7:00 am
Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer - Jan 27th, 2026 7:00 am
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer - Dec 22nd, 2025 7:00 am
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates - Nov 13th, 2025 2:05 pm
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Oct 4th, 2025 8:03 am
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates - Sep 29th, 2025 2:05 pm
Anebulo begins Phase I trial of IV cannabis antidote - Sep 26th, 2025 3:24 am
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity - Sep 25th, 2025 5:30 am
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives - Sep 12th, 2025 5:30 am
Cannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and Indivior - Jul 25th, 2025 8:51 am
Top Midday Gainers - Jul 23rd, 2025 12:00 pm
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock - Jul 23rd, 2025 6:00 am
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates - May 13th, 2025 2:05 pm
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Apr 27th, 2025 6:37 am